Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Axcel on its investment in AddPro
Mandate

Vinge has advised Axcel on its investment in AddPro

July 06, 2020 M&A EU, Competition and Regulatory Public Procurement Employment and Benefits Banking and Finance Commercial Agreements IT, Telecommunications and Outsourcing Intellectual Property

Axcel has signed an agreement to aquire a majority ownership stake in AddPro, a Swedish leading provider of IT and cloud services. AddPro’s current management team and founders will reinvest in the company alongside Axcel.

AddPro was founded 2000 in Malmö and has a total approximate revenue of SEK 800 million and close to 350 employees. AddPro is acquired from Adelis Equity Partners, founders, the management team and key employees. The transaction is subject to customary regulatory approvals. AddPro is the second investment in Axcel VI.

Vinge’s team consisted of partners Christina Kokko (M&A) and Mikael Ståhl (Banking & Finance) and associates Johanna Wiberg, Stina Bengtsson and Carl Fredrik Wachtmeister (M&A), Linn Adewald, Pauline Lagerstrand, Elias Lundin and Jolinn Uhlin (Banking & Finance), Mathilda Persson, Martin Boström and Fredrika Hjelmberg (Commercial Agreements & IT), Ilze Lukins and Anna Li (IP), Lisa Hörnqvist (GDPR), Veronika Garemark (Employment), Kristoffer Larsson (Real Estate), Kristoffer Sällfors (Public Procurement), Johan Wahlbom (Antitrust) and Nathalie Hughes (VDR assistant).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025